Antibodies are proteins produced by the immune system to identify and neutralize foreign objects like bacteria and viruses. They are crucial in diagnostics and therapeutics for various diseases.

How big is the Antibodies Market?

The global Antibodies Market size was estimated at USD 239.1 Billion in 2023 and is expected to reach USD 886.4 Billion in 2033.

What is the Antibodies Market growth?

The global Antibodies Market is expected to grow at a compound annual growth rate of 14.0%. From 2024 To 2033

Who are the key companies/players in the Antibodies Market?

Some of the key players in the Antibodies Markets are Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi, Eli Lilly and Co., Iovance Biotherapeutics, Inc., Ultragenyx Pharmaceutical Inc., and Kyowa Kirin Co., Ltd.

What are monoclonal antibodies?

Monoclonal antibodies (mAbs) are antibodies made by identical immune cells that are all clones of a unique parent cell. They can be designed to target specific cells or proteins and are used in the treatment of cancer, autoimmune diseases, and infectious diseases.

How has COVID-19 impacted the antibodies market?

COVID-19 positively impacted the antibodies market by increasing the demand for therapeutic and diagnostic antibodies, including the rapid development and approval of monoclonal antibodies for treatment and vaccines.

What are the main challenges facing the antibodies market?

Key challenges include the high cost of antibody production and treatment, regulatory hurdles, and the complexity of developing effective antibody therapies.

What are the major trends in the antibodies market?

Significant trends include the rise of personalized medicine, increasing investment in R&D for novel antibody therapies, and the growing market for biosimilars and antibody-drug conjugates (ADCs).

Global Antibodies Market By Drug Type, Monoclonal antibodies, Polyclonal antibodies, Antibody-drug complexes (ADCs), By Disease Indication, CNS Disorders, Cardiovascular Diseases, Cancer , Autoimmune Disorders , By End User (Hospitals , Long-term Care Facilities, Research institutes) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024–2033

Published date: July 2024
Report ID: 19180
Number of Pages: 389
Format:

- Novartis AG Company Profile
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Takeda Pharmaceutical Company Limited
- Amgen Inc.
- Biogen Inc.
- Bristol-Myers Squibb Company
- AbbVie Inc. Company Profile
- Sanofi Company Profile
- Eli Lilly and Co.
- Iovance Biotherapeutics Inc.
- Ultragenyx Pharmaceutical Inc.
- and Kyowa Kirin Co.Ltd.

Related Reports

Our Clients

Report ID 19180
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (71)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible